Comparison of Preoxygenation Techniques in Healthy Volunteers With Monitoring of End-tidal Oxygen Fraction (FeO₂) and Oxygen Reserve Index (ORI)
OXYGAME1
1 other identifier
interventional
30
1 country
1
Brief Summary
The objective of this physiological study is to compare two preoxygenation techniques (non-invasive ventilation combined with high-flow nasal oxygen versus non-invasive ventilation alone) by monitoring end-tidal oxygen fraction (FeO₂) and the Oxygen Reserve Index (ORI) during 3 minutes of preoxygenation in healthy volunteers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Mar 2026
Shorter than P25 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 30, 2025
CompletedFirst Posted
Study publicly available on registry
January 12, 2026
CompletedStudy Start
First participant enrolled
March 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 29, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 29, 2026
CompletedMay 14, 2026
May 1, 2026
2 months
December 30, 2025
May 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in end-tidal oxygen fraction (FeO2) at the end of each preoxygenation technique
FeO2 will be collected every 12 seconds during preoxygenation. The mean FeO2 value at 3 minutes will be used for comparison between techniques.
3 minutes
Secondary Outcomes (9)
Change in end-tidal oxygen fraction (FeO2) during each preoxygenation technique
3 minutes
Maximum FeO2 value
3 minutes
Average Oxygen Reserve Index (ORI) value
3 minutes
Maximum ORI value
3 minutes
Change in ORI during each preoxygenation technique
3 minutes
- +4 more secondary outcomes
Study Arms (2)
Non-invasive ventilation combined to high flow nasal cannula
EXPERIMENTAL\- NIV + HFNC: Non-invasive ventilation in pressure-controlled mode with inspiratory pressure adjusted to achieve a tidal volume of 6-8 mL/kg (in practice, inspiratory pressure between 5 and 10 cmH₂O) and a PEEP of 5 cmH₂O, combined with high-flow nasal cannula oxygen at 60 L/min with an FiO₂ of 100%
Non invasive ventilation
EXPERIMENTAL\- NIV alone in pressure-controlled mode with inspiratory pressure adjusted to achieve a tidal volume of 6-8 mL/kg (in practice, inspiratory pressure between 5 and 10 cmH₂O) and a PEEP of 5 cmH₂O
Interventions
Each preoxygenation session will last 3 minutes with the participant positioned at a 30° head-up angle. A washout period of 10 minutes will be applied between each preoxygenation session, and initiation of the second preoxygenation technique will require the Oxygen Reserve Index (ORI) to return to 0. Monitoring will include: * Oxygen Reserve Index (ORI) * End-tidal oxygen fraction (FeO₂) measured at the NIV mask * Peripheral oxygen saturation (SpO₂)
Each preoxygenation session will last 3 minutes with the participant positioned at a 30° head-up angle. A washout period of 10 minutes will be applied between each preoxygenation session, and initiation of the second preoxygenation technique will require the Oxygen Reserve Index (ORI) to return to 0. Monitoring will include: * Oxygen Reserve Index (ORI) * End-tidal oxygen fraction (FeO₂) measured at the NIV mask * Peripheral oxygen saturation (SpO₂)
Eligibility Criteria
You may qualify if:
- Male or female
- Healthy volunteer who has provided written informed consent
- Age \> 18 years
You may not qualify if:
- Long-term oxygen therapy
- Cardiac or pulmonary disease (including asthma)
- Presence of Raynaud's syndrome
- Claustrophobia
- Body mass index (BMI) ≥ 30 kg/m²
- Presence of nail polish preventing accurate SpO₂ and ORI measurement
- Under legal protection
- Incarcerated individuals
- Persons deprived of liberty
- Not affiliated to French social security
- Pregnant or breastfeeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Orléans
Orléans, 45067, France
Study Officials
- PRINCIPAL INVESTIGATOR
Mai-Anh NAH, MD
CHU d'Orléans
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 30, 2025
First Posted
January 12, 2026
Study Start
March 9, 2026
Primary Completion
April 29, 2026
Study Completion
April 29, 2026
Last Updated
May 14, 2026
Record last verified: 2026-05